Institutional Ownership
Lineage Cell Therapeutics In
CUSIP 53566P109COMLCTXQ1 2026
Institutional Holders
127
13F filers
Shares Held
101.94M
Aggregate institutional
Institutional Value
$160.26M
Q1 2026
Net New Holders
+10
22 new · 12 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions22
Increased37
Decreased25
Sold out12
Institutional Holders
127 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Broadwood Capital Inc | 49.56M | $78.31M | 0 | Held |
| 2 | Defender Capital, LLC. | 6.73M | $10.63M | −99.5K | Reduced |
| 3 | Millennium Management LLC | 5.56M | $8.79M | +3.45M | Added |
| 4 | Raffles Associates LP | 5.36M | $8.47M | 0 | Held |
| 5 | Fifth Third Bancorp | 4.60M | $7.27M | +4.60M | New |
| 6 | Blackrock, Inc. | 3.86M | $6.11M | +30.6K | Added |
| 7 | Armistice Capital, LLC | 3.18M | $5.03M | +3.18M | New |
| 8 | Marshall Wace, LLP | 3.07M | $4.84M | +1.70M | Added |
| 9 | Geode Capital Management, LLC | 2.52M | $3.99M | +61.9K | Added |
| 10 | Renaissance Technologies LLC | 2.13M | $3.36M | −279.7K | Reduced |
117 more institutional holders on Premium
See every fund holding Lineage Cell Therapeutics In, with full quarter-over-quarter share changes.
Unlock all holders